Successful co-encapsulation of benzoyl peroxide and chloramphenicol in liposomes by a novel manufacturing method - dual asymmetric centrifugation

European Journal of Pharmaceutical Sciences

Volumn 97, Issue , 2017, Pages 192-199

  Ingebrigtsen, Sveinung G ^a   Škalko Basnet, Nataša ^a   de Albuquerque Cavalcanti Jacobsen, Cristiane ^a   Holsæter, Ann Mari ^a  

^a UNIVERSITY OF TROMSØ   (Norway)

Author keywords

Acne; Benzoyl peroxide; Chloramphenicol; Co encapsulation; Dual asymmetric centrifugation; Liposomes

Indexed keywords

BENZOYL PEROXIDE; CHLORAMPHENICOL; DISTILLED WATER; LIPOSOME; PHOSPHATIDYLCHOLINE; PROPYLENE GLYCOL; ANTIINFECTIVE AGENT; DERMATOLOGICAL AGENT;

ARTICLE; CELL VIABILITY; CENTRIFUGATION; CONTROLLED STUDY; DISPERSITY; DRUG CYTOTOXICITY; DRUG FORMULATION; DRUG RELEASE; DUAL ASYMMETRIC CENTRIFUGATION; ENCAPSULATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; LIPOSOMAL DELIVERY; PARTICLE SIZE; PRIORITY JOURNAL; SUSTAINED DRUG RELEASE; ZETA POTENTIAL; CELL SURVIVAL; DRUG DELIVERY SYSTEM; DRUG EFFECTS; HUMAN; MEDICINAL CHEMISTRY; PHYSIOLOGY; PROCEDURES; SYNTHESIS; TUMOR CELL LINE;

ANTI-BACTERIAL AGENTS; BENZOYL PEROXIDE; CELL LINE, TUMOR; CELL SURVIVAL; CENTRIFUGATION; CHEMISTRY, PHARMACEUTICAL; CHLORAMPHENICOL; DERMATOLOGIC AGENTS; DRUG DELIVERY SYSTEMS; HUMANS; LIPOSOMES;

EID: 84996508865     PISSN: 09280987     EISSN: 18790720     Source Type: Journal    
DOI: 10.1016/j.ejps.2016.11.017     Document Type: Article

References (52)

1. Adrian, J.E., Wolf, A., Steinbach, A., Rössler, J., Süss, R., Targeted delivery to neuroblastoma of novel siRNA-anti-GD2-liposomes prepared by dual asymmetric centrifugation and sterol-based post-insertion method. Pharm. Res. 28 (2011), 2261–2272, 10.1007/s11095-011-0457-y.
2. Bartlett, G.R., Phosphorus assay in column chromatography. J. Biol. Chem. 234 (1959), 466–468.
3. Boer, Y., Pijnenburg, A., HPLC determination of chloramphenicol degradation in eye drops. Pharm. Weekbl. Sci. Ed. 5 (1983), 95–101, 10.1007/BF01960984.
4. Bonnekoh, B., Röding, J., Krueger, G.R., Ghyczy, M., Mahrle, G., Increase of lipid fluidity and suppression of proliferation resulting from liposome uptake by human keratinocytes in vitro. Br. J. Dermatol. 124 (1991), 333–340, 10.1111/j.1365-2133.1991.tb00593.x.
5. Burke, J.T., Wargin, W.A., Blum, M.R., High-pressure liquid chromatographic assay for chloramphenicol, chloramphenicol-3-monosuccinate, and chloramphenicol-1-monosuccinate. J. Pharm. Sci. 69 (1980), 909–912.
6. Burton, F.W., Gadde, R.R., McKenzie, W.L., High-pressure liquid chromatographic assay of benzoyl peroxide in dermatological gels and lotions. J. Pharm. Sci. 68 (1979), 280–283.
7. Castro, G.A., Ferreira, L.A.M., Novel vesicular and particulate drug delivery systems for topical treatment of acne. Expert Opin. Drug Deliv. 5 (2008), 665–679, 10.1517/17425247.5.6.665.
8. Chellquist, E.M., Gorman, W.G., Benzoyl peroxide solubility and stability in hydric solvents. Pharm. Res. 9 (1992), 1341–1346, 10.1023/a:1015873805080.
9. Durante-Mangoni, E., Utili, R., Zarrilli, R., Combination therapy in severe Acinetobacter baumannii infections: an update on the evidence to date. Future Microbiol 9 (2014), 773–789.
10. Engesland, A., Škalko-Basnet, N., Flaten, G.E., Phospholipid vesicle-based permeation assay and EpiSkin® in assessment of drug therapies destined for skin administration. J. Pharm. Sci. 104 (2015), 1119–1127, 10.1002/jps.24315.
11. Fayyaz, M., Mirza, I.A., Ahmed, Z., Abbasi, S.A., Hussain, A., Ali, S., In vitro susceptibility of chloramphenicol against methicillin-resistant Staphylococcus aureus. J. Coll. Physicians Surg. Pak. 23 (2013), 637–640 (doi:09.2013/JCPSP.637640).
12. Fischbach, M.A., Combination therapies for combating antimicrobial resistance. Curr. Opin. Microbiol. 14 (2011), 519–523, 10.1016/j.mib.2011.08.003.
13. Flaten, G.E., Palac, Z., Engesland, A., Filipović-Grčić, J., Vanić, Ž., Škalko-Basnet, N., In vitro skin models as a tool in optimization of drug formulation. Eur. J. Pharm. Sci. 75 (2015), 10–24, 10.1016/j.ejps.2015.02.018.
14. Foti, C., Romita, P., Borghi, A., Angelini, G., Bonamonte, D., Corazza, M., Contact dermatitis to topical acne drugs: a review of the literature. Dermatol. Ther. 28 (2015), 323–329, 10.1111/dth.12282.
15. Goyal, G., Garg, T., Malik, B., Chauhan, G., Rath, G., Goyal, A.K., Development and characterization of niosomal gel for topical delivery of benzoyl peroxide. Drug Deliv. 22 (2015), 1027–1042, 10.3109/10717544.2013.855277.
16. Gupta, A., Singh, S., Kotla, N.G., Webster, T.J., Formulation and evaluation of a topical niosomal gel containing a combination of benzoyl peroxide and tretinoin for antiacne activity. Int. J. Nanomedicine 10 (2014), 171–182, 10.2147/IJN.S70449.
17. Tripathi, S.V., Gustafson, C.J., Huang, K.E., Feldman, S.R., Side effects of common acne treatments. Expert Opin. Drug Saf. 12 (2013), 39–51, 10.1517/14740338.2013.740456.
18. Haque, T., Rahman, K.M., Thurston, D.E., Hadgraft, J., Lane, M.E., Topical therapies for skin cancer and actinic keratosis. Eur. J. Pharm. Sci. 77 (2015), 279–289, 10.1016/j.ejps.2015.06.013.
19. Hirsch, M., Ziroli, V., Helm, M., Massing, U., Preparation of small amounts of sterile siRNA-liposomes with high entrapping efficiency by dual asymmetric centrifugation (DAC). J. Control. Release 135 (2009), 80–88, 10.1016/j.jconrel.2008.11.029.
20. Hongo, T., Hikage, S., Sato, A., Stability of benzoyl peroxide in methyl alcohol. Dent. Mater. J. 25 (2006), 298–302, 10.4012/dmj.25.298.
21. Ingebrigtsen, S.G., Škalko-Basnet, N., Holsæter, A.M., Development and optimization of a new processing approach for manufacturing topical liposomes-in-hydrogel drug formulations by dual asymmetric centrifugation. Drug Dev. Ind. Pharm. 42 (2016), 1375–1383, 10.3109/03639045.2015.1135940.
22. Jøraholmen, M.W., Vanić, Ž., Tho, I., Škalko-Basnet, N., Chitosan-coated liposomes for topical vaginal therapy: assuring localized drug effect. Int. J. Pharm. 472 (2014), 94–101, 10.1016/j.ijpharm.2014.06.016.
23. Kalita, S., Devi, B., Kandimalla, R., Sharma, K.K., Sharma, A., Kalita, K., Kataki, A.C., Kotoky, J., Chloramphenicol encapsulated in poly-ε-caprolactone–pluronic composite: nanoparticles for treatment of MRSA-infected burn wounds. Int. J. Nanomedicine 10 (2015), 2971–2984, 10.2147/IJN.S75023.
24. Kumar, V., Banga, A.K., Intradermal and follicular delivery of adapalene liposomes. Drug Dev. Ind. Pharm. 42 (2016), 871–879, 10.3109/03639045.2015.1082580.
25. Ladbrooke, B.D., Williams, R.M., Chapman, D., Studies on lecithin-cholesterol-water interactions by differential scanning calorimetry and X-ray diffraction. Biochim. Biophys. Acta Biomembr. 150 (1968), 333–340, 10.1016/0005-2736(68)90132-6.
26. Landewé, R.B.M., Boers, M., Verhoeven, A.C., Westhovens, R., Van De Laar, M.A.F.J., Markusse, H.M., Van Denderen, J.C., Westedt, M.L., Peeters, A.J., Dijkmans, B.A.C., Jacobs, P., Boonen, A., Van Der Heijde, D.M.F.M., Van Der Linden, S., COBRA combination therapy in patients with early rheumatoid arthritis: long-term structural benefits of a brief intervention. Arthritis Rheum. 46 (2002), 347–356.
27. Lieb, L.M., Ramachandran, C., Egbaria, K., Weiner, N., Topical delivery enhancement with multilamellar liposomes into pilosebaceous units: I. In vitro evaluation using fluorescent techniques with the hamster ear model. J. Investig. Dermatol. 99 (1992), 108–113.
28. Massing, U., Cicko, S., Ziroli, V., Dual asymmetric centrifugation (DAC) — a new technique for liposome preparation. J. Control. Release 125 (2008), 16–24, 10.1016/j.jconrel.2007.09.010.
29. Meier, S., Pütz, G., Massing, U., Hagemeyer, C.E., von Elverfeldt, D., Meibner, M., Ardipradja, K., Barnert, S., Peter, K., Bode, C., Schubert, R., von zur Muhlen, C., Immuno-magnetoliposomes targeting activated platelets as a potentially human-compatible MRI contrast agent for targeting atherothrombosis. Biomaterials 53 (2015), 137–148, 10.1016/j.biomaterials.2015.02.088.
30. Mezei, M., Gulasekharam, V., Liposomes - a selective drug delivery system for the topical route of administration I. Lotion dosage form. Life Sci. 26 (1980), 1473–1477, 10.1016/0024-3205(80)90268-4.
31. Mills, O.H., Kligman, A.M., Pochi, P., Comite, H., Comparing 2.5%, 5%, and 10% benzoyl peroxide on inflammatory acne vulgaris. Int. J. Dermatol. 25 (1986), 664–667, 10.1111/j.1365-4362.1986.tb04534.x.
32. Mosmann, T., Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Methods 65 (1983), 55–63, 10.1016/0022-1759(83)90303-4.
33. Okamoto, K., Ikeda, F., Kanayama, S., Nakajima, A., Matsumoto, T., Ishii, R., Umehara, M., Gotoh, N., Hayashi, N., Iyoda, T., Matsuzaki, K., Matsumoto, S., Kawashima, M., In vitro antimicrobial activity of benzoyl peroxide against Propionibacterium acnes assessed by a novel susceptibility testing method. J. Infect. Chemother., 2016, 10.1016/j.jiac.2015.12.010.
34. Parmentier, J., Hofhaus, G., Thomas, S., Cuesta, L.C., Gropp, F., Schröder, R., Hartmann, K., Fricker, G., Improved oral bioavailability of human growth hormone by a combination of liposomes containing bio-enhancers and tetraether lipids and omeprazole. J. Pharm. Sci. 103 (2014), 3985–3993, 10.1002/jps.24215.
35. Patel, V.B., Misra, A., Marfatia, Y.S., Topical liposomal gel of tretinoin for the treatment of acne: research and clinical implications. Pharm. Dev. Technol. 5 (2000), 455–464, 10.1081/PDT-100102029.
36. Patel, V.B., Misra, A.N., Marfatia, Y.S., Preparation and comparative clinical evaluation of liposomal gel of benzoyl peroxide for acne. Drug Dev. Ind. Pharm. 27 (2001), 863–870, 10.1081/DDC-100107251.
37. Pavelić, Ž., Škalko-Basnet, N., Jalšenjak, I., Liposomes containing drugs for treatment of vaginal infections. Eur. J. Pharm. Sci. 8 (1999), 345–351, 10.1016/S0928-0987(99)00033-0.
38. Pitto, M., Palestini, P., Ferraretto, A., Marazzi, M., Donati, V., Falcone, L., Masserini, M., Interaction of liposomes composed of phospholipids, GM1 ganglioside and cholesterol with human keratinocytes in culture. Arch. Dermatol. Res. 291 (1999), 232–237, 10.1007/s004030050399.
39. Saiz, A.I., Manrique, G.D., Fritz, R., Determination of benzoyl peroxide and benzoic acid levels by HPLC during wheat flour bleaching process. J. Agric. Food Chem. 49 (2001), 98–102, 10.1021/jf9912304.
40. Sample, R.H., Glick, M.R., Kleiman, M.B., Smith, J.W., Oei, T.O., High-pressure liquid chromatographic assay of chloramphenicol in biological fluids. Antimicrob. Agents Chemother. 15 (1979), 491–493.
41. Shaikh, I.M., Tan, K.-B.B., Chaudhury, A., Liu, Y., Tan, B.M.J.B.J.B.M.J.B.-J., Tan, B.M.J.B.J.B.M.J.B.-J., Chiu, G.N.C.C., Liposome co-encapsulation of synergistic combination of irinotecan and doxorubicin for the treatment of intraperitoneally grown ovarian tumor xenograft. J. Control. Release 172 (2013), 852–861, 10.1016/j.jconrel.2013.10.025.
42. Škalko, N., Čajkovac, M., Jalšenjak, I., Liposomes with clindamycin hydrochloride in the therapy of acne vulgaris. Int. J. Pharm. 85 (1992), 97–101, 10.1016/0378-5173(92)90138-R.
43. Tian, W., Schulze, S., Brandl, M., Winter, G., Vesicular phospholipid gel-based depot formulations for pharmaceutical proteins: development and in vitro evaluation. J. Control. Release 142 (2010), 319–325, 10.1016/j.jconrel.2009.11.006.
44. Vanić, Ž., Phospholipid vesicles for enhanced drug delivery in dermatology. J. Drug Discov. Dev. Deliv. 2 (2015), 1–9.
45. Vyas, A., Kumar Sonker, A., Gidwani, B., Carrier-based drug delivery system for treatment of acne. Sci. World J., 2014, 2014, 10.1155/2014/276260.
46. Wagner, A., Vorauer-Uhl, K., Liposome technology for industrial purposes. J. Drug Deliv. 2011 (2011), 1–9, 10.1155/2011/591325.
47. Waller, J.M., Dreher, F., Behnam, S., Ford, C., Lee, C., Tiet, T., Weinstein, G.D., Maibach, H.I., “Keratolytic” properties of benzoyl peroxide and retinoic acid resemble salicylic acid in man. Skin Pharmacol. Physiol. 19 (2006), 283–289, 10.1159/000093984.
48. Walsh, T.R., Efthimiou, J., Dréno, B., Systematic review of antibiotic resistance in acne: an increasing topical and oral threat. Lancet Infect. Dis. 16 (2016), e23–e33, 10.1016/S1473-3099(15)00527-7.
49. Williams, H.C., Dellavalle, R.P., Garner, S., Acne vulgaris. Lancet 379 (2012), 361–372, 10.1016/S0140-6736(11)60321-8.
50. Yang, D., Pornpattananangkul, D., Nakatsuji, T., Chan, M., Carson, D., Huang, C.-M., Zhang, L., The antimicrobial activity of liposomal lauric acids against Propionibacterium acnes. Biomaterials 30 (2009), 6035–6040, 10.1016/j.biomaterials.2009.07.033.
51. Zaenglein, A.L., Pathy, A.L., Schlosser, B.J., Alikhan, A., Baldwin, H.E., Berson, D.S., Bowe, W.P., Graber, E.M., Harper, J.C., Kang, S., Keri, J.E., Leyden, J.J., Reynolds, R.V., Silverberg, N.B., Stein Gold, L.F., Tollefson, M.M., Weiss, J.S., Dolan, N.C., Sagan, A.A., Stern, M., Boyer, K.M., Bhushan, R., Guidelines of care for the management of acne vulgaris. J. Am. Acad. Dermatol. 74 (2016), 945–973e33, 10.1016/j.jaad.2015.12.037.
52. Zucker, D., Andriyanov, A.V., Steiner, A., Raviv, U., Characterization of PEGylated nanoliposomes co-remotely loaded with topotecan and vincristine: relating structure and pharmacokinetics to therapeutic efficacy. J. Control. Release 160 (2012), 281–289, 10.1016/j.jconrel.2011.10.003.